156 related articles for article (PubMed ID: 31525809)
1. Molecular Testing on Pleural Fluid Samples.
Oh S; Ronaghi R; Cai G
Semin Respir Crit Care Med; 2019 Jun; 40(3):340-346. PubMed ID: 31525809
[TBL] [Abstract][Full Text] [Related]
2. Transudates in malignancy: still a role for pleural fluid.
Gonlugur TE; Gonlugur U
Ann Acad Med Singap; 2008 Sep; 37(9):760-3. PubMed ID: 18989492
[TBL] [Abstract][Full Text] [Related]
3. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
Assi Z; Caruso JL; Herndon J; Patz EF
Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
[TBL] [Abstract][Full Text] [Related]
5. Useful tests on the pleural fluid in the management of patients with pleural effusions.
Light RW
Curr Opin Pulm Med; 1999 Jul; 5(4):245-9. PubMed ID: 10407695
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion.
Elsammak MY; Attia A; Hassan HA; Zaytoun TM; Shorman M; Suleman M
Tumour Biol; 2012 Oct; 33(5):1701-7. PubMed ID: 22684816
[TBL] [Abstract][Full Text] [Related]
7. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
8. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of pleural fluid cytologic examination].
Zablockis R; Nargela R
Medicina (Kaunas); 2002; 38(12):1171-8. PubMed ID: 12552157
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma.
Emri S; Ustündağ Y; Budak T; Karakoca Y; Ozdemir O
Monaldi Arch Chest Dis; 1997 Aug; 52(4):335-8. PubMed ID: 9401361
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
13. Decision making and algorithm for the management of pleural effusions.
Quinn T; Alam N; Aminazad A; Marshall MB; Choong CK
Thorac Surg Clin; 2013 Feb; 23(1):11-6, v. PubMed ID: 23206713
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pro-inflammatory cytokine and pro-angiogenesis factor in differentiating malignant from benign exudative effusion.
Elhefny RA; Shaban MM; Shaker OG
Clin Respir J; 2017 Jan; 11(1):49-57. PubMed ID: 25832725
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
Adell E; Dejmek A
Diagn Cytopathol; 2014 Dec; 42(12):1051-7. PubMed ID: 24692425
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
Porcel JM
Curr Opin Pulm Med; 2019 Jul; 25(4):362-368. PubMed ID: 31082996
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
19. An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
Miller LJ; Holmes IM; Lew M
Arch Pathol Lab Med; 2024 Apr; 148(4):409-418. PubMed ID: 37622452
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural disease: a pragmatic guide to diagnosis.
Chang CH; Ost DE
Curr Opin Pulm Med; 2022 Jul; 28(4):282-287. PubMed ID: 35749791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]